Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Asthma

  Free Subscription


Articles published in Pulm Pharmacol Ther

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    October 2021
  1. SUTTON SS, Magagnoli J, Cummings TH, Hardin JW, et al
    Leukotriene Inhibition and the Risk of Lung Cancer among U.S. Veterans with Asthma.
    Pulm Pharmacol Ther. 2021 Oct 15:102084. doi: 10.1016/j.pupt.2021.102084.
    PubMed     Abstract available


  2. ALIDA B, Stefania P, Noemi CM, Maria I, et al
    Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: tips for facing the second wave.
    Pulm Pharmacol Ther. 2021 Oct 7:102083. doi: 10.1016/j.pupt.2021.102083.
    PubMed     Abstract available


  3. VAIDYA S, Ziegler D, Tanase AM, Malmqvist U, et al
    Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers.
    Pulm Pharmacol Ther. 2021;70:102019.
    PubMed     Abstract available


    September 2021
  4. BAAN EJ, Hoeve CE, de Ridder M, Demoen L, et al
    The ALPACA study: (In)Appropriate LAMA Prescribing in Asthma: a Cohort Analysis.
    Pulm Pharmacol Ther. 2021 Sep 20:102074. doi: 10.1016/j.pupt.2021.102074.
    PubMed     Abstract available


    August 2021
  5. AL-THAGFAN SS, Ahmed S, Emara MM, Awadallah MF, et al
    Impacts of deficiency in vitamin D derivatives on disease severity in adult bronchial asthma patients.
    Pulm Pharmacol Ther. 2021 Aug 18:102073. doi: 10.1016/j.pupt.2021.102073.
    PubMed     Abstract available


    July 2021
  6. BUHL R, Nikolaev I, Tillmann HC, Vaidya S, et al
    Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma.
    Pulm Pharmacol Ther. 2021 Jul 27:102068. doi: 10.1016/j.pupt.2021.102068.
    PubMed     Abstract available


  7. LANDI C, Vantaggiato L, Shaba E, Cameli P, et al
    Differential redox proteomic profiles of serum from severe asthma patients after one month of benralizumab and mepolizumab treatment.
    Pulm Pharmacol Ther. 2021;70:102060.
    PubMed     Abstract available


    June 2021
  8. KAWAGOE J, Yuki M, Kikuchi R, Takahashi M, et al
    Differential effects of dexamethasone and roflumilast on asthma in mice with or without short cigarette smoke exposure.
    Pulm Pharmacol Ther. 2021 Jun 29:102052. doi: 10.1016/j.pupt.2021.102052.
    PubMed     Abstract available


    May 2021
  9. MOTAMED H, Verki MM, Nematollahi AV, Hesam S, et al
    Evaluation of Efficacy of Nebulized Low Molecular Weight Heparin as an Adjunctive Extra Treatment for Acute Mild-Moderate Asthma Attack; a Randomized Clinical Trial Study.
    Pulm Pharmacol Ther. 2021 May 11:102037. doi: 10.1016/j.pupt.2021.102037.
    PubMed     Abstract available


    April 2021
  10. ZOU B, Fu Y, Cao C, Pan D, et al
    Gentiopicroside ameliorates ovalbumin-induced airway inflammation in a mouse model of allergic asthma via regulating SIRT1/NF-kappaB signaling pathway.
    Pulm Pharmacol Ther. 2021 Apr 19:102034. doi: 10.1016/j.pupt.2021.102034.
    PubMed     Abstract available


  11. AKABA T, Kondo M, Kobayashi F, Honda N, et al
    Characteristics of patients with severe asthma who experienced treatment failure with omalizumab.
    Pulm Pharmacol Ther. 2021;68:102032.
    PubMed     Abstract available


    February 2021
  12. HUANG M, Wei Y, Dong J
    Epimedin C modulates the balance between Th9 cells and Treg cells through negative regulation of noncanonical NF-kappaB pathway and MAPKs activation to inhibit airway inflammation in the ovalbumin-induced murine asthma model.
    Pulm Pharmacol Ther. 2021 Feb 23:102005. doi: 10.1016/j.pupt.2021.102005.
    PubMed     Abstract available


  13. HUR J, Kang JY, Kim YK, Lee SY, et al
    Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model.
    Pulm Pharmacol Ther. 2021 Feb 12:102003. doi: 10.1016/j.pupt.2021.102003.
    PubMed     Abstract available


  14. SRIBOONYONG T, Kawamatawong T, Sriwantana T, Srihirun S, et al
    Efficacy and safety of inhaled nebulized sodium nitrite in asthmatic patients.
    Pulm Pharmacol Ther. 2021;66:101984.
    PubMed     Abstract available


    November 2020
  15. DI BONA D, Minenna E, Albanesi M, Nettis E, et al
    Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort.
    Pulm Pharmacol Ther. 2020;64:101974.
    PubMed     Abstract available


    October 2020
  16. BUSBY J, Holweg C, Chai A, Bradding P, et al
    Using prednisolone and cortisol assays to assess adherence in oral corticosteroid dependant asthma: an analysis of test-retest repeatability.
    Pulm Pharmacol Ther. 2020 Oct 9:101951. doi: 10.1016/j.pupt.2020.101951.
    PubMed     Abstract available


  17. MATSUNO O, Minamoto S
    Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps.
    Pulm Pharmacol Ther. 2020;64:101965.
    PubMed     Abstract available


  18. MENZELLA F, Ruggiero P, Galeone C, Scelfo C, et al
    Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma.
    Pulm Pharmacol Ther. 2020;64:101966.
    PubMed     Abstract available


  19. LI Y, Li X, Zhou W, Yu Q, et al
    ORMDL3 modulates airway epithelial cell repair in children with asthma under glucocorticoid treatment via regulating IL-33.
    Pulm Pharmacol Ther. 2020 Oct 6:101963. doi: 10.1016/j.pupt.2020.101963.
    PubMed     Abstract available


    September 2020
  20. ASANO K, Sumi K, Yoshisue H, Nakamura N, et al
    Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillance.
    Pulm Pharmacol Ther. 2020 Sep 17:101950. doi: 10.1016/j.pupt.2020.101950.
    PubMed     Abstract available


  21. RENNER A, Marth K, Patocka K, Idzko M, et al
    Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data.
    Pulm Pharmacol Ther. 2020;64:101946.
    PubMed     Abstract available


    April 2020
  22. ELGENDY MO, Hassan AH, Saeed H, Abdelrahim ME, et al
    Asthmatic children and MDI verbal inhalation technique counseling.
    Pulm Pharmacol Ther. 2020;61:101900.
    PubMed     Abstract available


  23. SPOSATO B, Camiciottoli G, Bacci E, Scalese M, et al
    Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life.
    Pulm Pharmacol Ther. 2020;61:101899.
    PubMed     Abstract available


    February 2020
  24. CARPAGNANO GE, Scioscia G, Lacedonia D, Stornelli SR, et al
    Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients.
    Pulm Pharmacol Ther. 2020;60:101879.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: